Maiken Keson-Brookes
Plus aucun poste en cours
Fortune : 243 377 $ au 29/02/2024
Profil
Maiken Keson-Brookes holds the position of Chief Legal Officer for Mural Oncology Plc.
In the past she was Associate General Counsel at Biogen, Inc., Secretary & Chief Legal Officer for Rubius Therapeutics, Inc., Secretary of Synlogic, Inc., Vice President & General Counsel at FORUM Pharmaceuticals, Inc., Senior Vice President & General Counsel at uniQure NV and Secretary & General Counsel at Cxloyalty Inernational Ltd.
Ms. Keson-Brookes received a graduate degree from King's College London.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
0,28% | 01/03/2024 | 46 007 ( 0,28% ) | 243 377 $ | 29/02/2024 |
Postes actifs de Maiken Keson-Brookes
Sociétés | Poste | Début |
---|
Anciens postes connus de Maiken Keson-Brookes
Sociétés | Poste | Fin |
---|---|---|
RUBIUS THERAPEUTICS | General Counsel | 15/11/2022 |
UNIQURE N.V. | General Counsel | 01/07/2017 |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | General Counsel | 01/06/2016 |
BIOGEN INC. | Corporate Officer/Principal | 01/01/2009 |
SYNLOGIC, INC. | General Counsel | 01/11/2019 |
Formation de Maiken Keson-Brookes
King's College London | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
BIOGEN INC. | Health Technology |
UNIQURE N.V. | Health Technology |
SYNLOGIC, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Cxloyalty Inernational Ltd.
Cxloyalty Inernational Ltd. Miscellaneous Commercial ServicesCommercial Services Cxloyalty Inernational Ltd. provides marketing services to financial institutions and insurance companies. It offers sentinel card protection, a software protection, fraud insurance product for personal computer users, protection, insurance, travel, leisure products and services. The company was founded in 1971 and is headquartered in Slough, the United Kingdom. | Commercial Services |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |